Targeted and untargeted serum NMR metabolomics to reveal initial kidney disease in diabetes mellitus.
Lucio-Gutiérrez JR, Cordero-Pérez P, Ávila-Velázquez JL, Torres-González L, Farías-Navarro IC, Govea-Torres G, Sánchez-Martínez C, García-Hernández PA, Coello-Bonilla J, Pérez-Trujillo M, Parella T, Waksman-Minsky NH, Saucedo AL.
Lucio-Gutiérrez JR, et al. Among authors: sanchez martinez c.
J Pharm Biomed Anal. 2024 Sep 1;247:116240. doi: 10.1016/j.jpba.2024.116240. Epub 2024 May 26.
J Pharm Biomed Anal. 2024.
PMID: 38820837